Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility

Wednesday, June 02, 2021

POINT Biopharma Inc a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients announced today that the US Nuclear Regulatory Commission NRC has issued a Materials License for its new pro...

Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.

Tuesday, June 01, 2021

Nexturn Bio Inc a subsidiary of Nexturn Bioscience Co Ltd announced on May th that it had acquired a stake in RosVivo Therapeutics Inc Rosvivo an American new drug developer for about million US dollars As a result Nexturn Bio Inc strengthens its c...

Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services

Tuesday, June 01, 2021

Samsung Biologics a leading global CDMO providing endtoend contract development and manufacturing services today announced its plans to add mRNA vaccine drug substance DS manufacturing capability to the current facility in Songdo ready for cGMP opera...

Seelos Therapeutics Receives European Orphan Drug Designation for SLS-005 (Trehalose) in Amyotrophic LateralSclerosis (ALS)

Friday, May 28, 2021

Seelos Therapeutics Inc a clinicalstage biopharmaceutical company focused on thedevelopment of therapies for central nervous system disorders and rare diseases today announced it has received European OrphanDrug Designation for SLS in amyotrophic lat...

Antengene Announces First Patient Dosed in Phase I/II Trial of Eltanexor for the Treatment of Myelodysplastic Syndrome

Friday, May 28, 2021

Antengene Corporation Limited a leading innovative biopharmaceutical company dedicated to discovering developing and commercializing global firstinclass andor bestinclass therapeutics in hematology and oncology today announced the dosing of the first...

Menarini Silicon Biosystems launches new breakthrough DEPArray™ PLUS image-based cell sorter to isolate rare cells with single cell precision

Thursday, May 27, 2021

Menarini Silicon Biosystems a pioneer of liquid biopsy and single cell technologies announced today the launch of the new highly automated DEPArray PLUS now available with fluorescent channels This robust imagebased cellsorting technology combines m...

BioInvent and Transgene receive IND approval from the U.S. FDA for BT-001, a novel oncolytic virus for the treatment of solid tumors

Thursday, May 27, 2021

BioInvent International AB a biotech company focused on the discovery and development of novel and firstinclass immunemodulatory antibodies for cancer immunotherapy and Transgene Euronext Paris TNG a biotech company that designs and develops virusbas...

Ajinomoto Bio-Pharma Services Expands Fill Finish Capacity with New Multi-Purpose Fill Suite

Wednesday, May 26, 2021

Ajinomoto BioPharma Services a leading provider of biopharmaceutical contract development and manufacturing services today announced it will soon open a high speed multipurpose fill finish line in its stateoftheart commercial manufacturing facility l...

Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases

Wednesday, May 26, 2021

Alloy Therapeutics and Pyxis Oncology announced the formation of a joint venture named Kyma Therapeutics to develop immunemodulating antibodies for novel targets in cancer and autoimmune diseases Kyma Therapeutics will advance programs directed to im...

Dorian and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery

Tuesday, May 25, 2021

Shanghai Stock Exchange listed company HitGen Inc HitGen today announced that it has entered into a research collaboration agreement with Dorian Therapeutics Inc Dorian a private biotechnology company developing senoblockers a new class of therapeuti...